The Gastrointestinal Diagnostics Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Test Type, Endoscopy, Blood test, H. pylori test, Calprotectin test, Immunoglobulin A test, Others), By Technology (ELISA, PCR, Microbiology, Others), By Application (Infection, Inflammatory Bowel Disease, Gastroesophageal Reflux Disease (GERD), Cancer, Others), By Test Location (Central laboratories, Point-of-Care).
The gastrointestinal diagnostics market in 2024 serves the demand for medical devices, diagnostic tests, and imaging technologies used in the diagnosis, monitoring, and management of gastrointestinal (GI) disorders, digestive diseases, and functional bowel disorders affecting the stomach, esophagus, intestines, and colon, providing clinicians and gastroenterologists with comprehensive diagnostic tools and procedures for evaluating GI function, anatomy, and pathology. Gastrointestinal diagnostics encompass a broad range of modalities and procedures, including endoscopy (esophagogastroduodenoscopy, colonoscopy), capsule endoscopy, gastrointestinal motility testing, fecal occult blood testing (FOBT), stool analysis, and breath tests for assessing GI transit, absorption, secretion, and microbiome composition, facilitating the diagnosis of gastrointestinal cancers, inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and gastroesophageal reflux disease (GERD). Market dynamics are driven by factors such as the increasing prevalence of GI disorders and digestive health conditions, the growing demand for non-invasive and minimally invasive diagnostic techniques, and advancements in gastrointestinal imaging, endoscopic devices, and molecular diagnostics for improved disease detection, staging, and treatment monitoring. Collaboration between gastrointestinal device manufacturers, gastroenterologists, and medical research institutions drives innovation and market expansion in gastrointesti
One prominent trend in the Gastrointestinal Diagnostics market is the increasing adoption of non-invasive diagnostic techniques. Patients and healthcare providers are increasingly preferring non-invasive diagnostic methods due to their convenience, safety, and reduced discomfort compared to traditional invasive procedures. Non-invasive gastrointestinal diagnostics, including imaging modalities like MRI, CT scans, and ultrasound, as well as non-invasive tests such as fecal occult blood tests (FOBT) and stool antigen tests, are gaining popularity for their ability to provide accurate diagnostic information without the need for invasive procedures, leading to improved patient compliance and diagnostic accuracy.
A key driver in the Gastrointestinal Diagnostics market is the growing incidence of gastrointestinal disorders and diseases globally. Factors such as changing dietary habits, sedentary lifestyles, aging populations, and increasing prevalence of conditions like inflammatory bowel disease (IBD), gastroesophageal reflux disease (GERD), colorectal cancer, and peptic ulcers are driving the demand for gastrointestinal diagnostic tests and procedures. Early detection and diagnosis of gastrointestinal disorders are crucial for timely intervention and effective management, leading to a higher demand for diagnostic modalities and tests in both clinical and screening settings.
An opportunity for market growth in the Gastrointestinal Diagnostics market lies in technological advancements in diagnostic modalities, particularly in the development of advanced imaging techniques and molecular diagnostic tools. Innovations such as capsule endoscopy, virtual colonoscopy, and molecular biomarker assays are revolutionizing gastrointestinal diagnostics by offering higher sensitivity, specificity, and patient comfort compared to conventional methods. Additionally, the integration of artificial intelligence (AI) and machine learning algorithms into diagnostic platforms enhances diagnostic accuracy and efficiency. Companies investing in research and development to innovate and commercialize next-generation gastrointestinal diagnostic technologies stand to capitalize on the growing demand for advanced diagnostic solutions and gain a competitive edge in the market.
By Test Type
Endoscopy
Blood test
H. pylori test
Calprotectin test
Immunoglobulin A test
Others
By Technology
ELISA
PCR
Microbiology
Others
By Application
Infection
Inflammatory Bowel Disease
Gastroesophageal Reflux Disease (GERD)
Cancer
Others
By Test Location
Central laboratories
Point-of-Care
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Abbott
Beckman Coulter Inc
BIOMERIEUX
DiaSorin S.p.A
F. Hoffmann-La Roche Ltd
Hologic Inc
Meridian Bioscience
QIAGEN
Siemens Healthineers AG
*- List Not Exhaustive
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Gastrointestinal Diagnostics Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Gastrointestinal Diagnostics Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Gastrointestinal Diagnostics Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Gastrointestinal Diagnostics Market Size Outlook, $ Million, 2021 to 2030
3.2 Gastrointestinal Diagnostics Market Outlook by Type, $ Million, 2021 to 2030
3.3 Gastrointestinal Diagnostics Market Outlook by Product, $ Million, 2021 to 2030
3.4 Gastrointestinal Diagnostics Market Outlook by Application, $ Million, 2021 to 2030
3.5 Gastrointestinal Diagnostics Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Gastrointestinal Diagnostics Market Industry
4.2 Key Market Trends in Gastrointestinal Diagnostics Market Industry
4.3 Potential Opportunities in Gastrointestinal Diagnostics Market Industry
4.4 Key Challenges in Gastrointestinal Diagnostics Market Industry
5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global Gastrointestinal Diagnostics Market Share by Company (%), 2023
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Gastrointestinal Diagnostics Market Outlook By Segments
7.1 Gastrointestinal Diagnostics Market Outlook by Segments
By Test Type
Endoscopy
Blood test
H. pylori test
Calprotectin test
Immunoglobulin A test
Others
By Technology
ELISA
PCR
Microbiology
Others
By Application
Infection
Inflammatory Bowel Disease
Gastroesophageal Reflux Disease (GERD)
Cancer
Others
By Test Location
Central laboratories
Point-of-Care
8 North America Gastrointestinal Diagnostics Market Analysis And Outlook To 2030
8.1 Introduction to North America Gastrointestinal Diagnostics Markets in 2024
8.2 North America Gastrointestinal Diagnostics Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Gastrointestinal Diagnostics Market size Outlook by Segments, 2021-2030
By Test Type
Endoscopy
Blood test
H. pylori test
Calprotectin test
Immunoglobulin A test
Others
By Technology
ELISA
PCR
Microbiology
Others
By Application
Infection
Inflammatory Bowel Disease
Gastroesophageal Reflux Disease (GERD)
Cancer
Others
By Test Location
Central laboratories
Point-of-Care
9 Europe Gastrointestinal Diagnostics Market Analysis And Outlook To 2030
9.1 Introduction to Europe Gastrointestinal Diagnostics Markets in 2024
9.2 Europe Gastrointestinal Diagnostics Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Gastrointestinal Diagnostics Market Size Outlook By Segments, 2021-2030
By Test Type
Endoscopy
Blood test
H. pylori test
Calprotectin test
Immunoglobulin A test
Others
By Technology
ELISA
PCR
Microbiology
Others
By Application
Infection
Inflammatory Bowel Disease
Gastroesophageal Reflux Disease (GERD)
Cancer
Others
By Test Location
Central laboratories
Point-of-Care
10 Asia Pacific Gastrointestinal Diagnostics Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific Gastrointestinal Diagnostics Markets in 2024
10.2 Asia Pacific Gastrointestinal Diagnostics Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Gastrointestinal Diagnostics Market size Outlook by Segments, 2021-2030
By Test Type
Endoscopy
Blood test
H. pylori test
Calprotectin test
Immunoglobulin A test
Others
By Technology
ELISA
PCR
Microbiology
Others
By Application
Infection
Inflammatory Bowel Disease
Gastroesophageal Reflux Disease (GERD)
Cancer
Others
By Test Location
Central laboratories
Point-of-Care
11 South America Gastrointestinal Diagnostics Market Analysis And Outlook To 2030
11.1 Introduction to South America Gastrointestinal Diagnostics Markets in 2024
11.2 South America Gastrointestinal Diagnostics Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Gastrointestinal Diagnostics Market size Outlook by Segments, 2021-2030
By Test Type
Endoscopy
Blood test
H. pylori test
Calprotectin test
Immunoglobulin A test
Others
By Technology
ELISA
PCR
Microbiology
Others
By Application
Infection
Inflammatory Bowel Disease
Gastroesophageal Reflux Disease (GERD)
Cancer
Others
By Test Location
Central laboratories
Point-of-Care
12 Middle East And Africa Gastrointestinal Diagnostics Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa Gastrointestinal Diagnostics Markets in 2024
12.2 Middle East and Africa Gastrointestinal Diagnostics Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Gastrointestinal Diagnostics Market size Outlook by Segments, 2021-2030
By Test Type
Endoscopy
Blood test
H. pylori test
Calprotectin test
Immunoglobulin A test
Others
By Technology
ELISA
PCR
Microbiology
Others
By Application
Infection
Inflammatory Bowel Disease
Gastroesophageal Reflux Disease (GERD)
Cancer
Others
By Test Location
Central laboratories
Point-of-Care
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbott
Beckman Coulter Inc
BIOMERIEUX
DiaSorin S.p.A
F. Hoffmann-La Roche Ltd
Hologic Inc
Meridian Bioscience
QIAGEN
Siemens Healthineers AG
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Test Type
Endoscopy
Blood test
H. pylori test
Calprotectin test
Immunoglobulin A test
Others
By Technology
ELISA
PCR
Microbiology
Others
By Application
Infection
Inflammatory Bowel Disease
Gastroesophageal Reflux Disease (GERD)
Cancer
Others
By Test Location
Central laboratories
Point-of-Care
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
The global Gastrointestinal Diagnostics Market is one of the lucrative growth markets, poised to register a 4.8% growth (CAGR) between 2024 and 2032.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Abbott, Beckman Coulter Inc, BIOMERIEUX, DiaSorin S.p.A, F. Hoffmann-La Roche Ltd, Hologic Inc, Meridian Bioscience, QIAGEN, Siemens Healthineers AG
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume